Board-Certified Psychiatric Provider | Los Angeles, West Hollywood & Beverly Hills | Cedars-Sinai Medical Office Towers

You Don't Have to Keep Living With Depression That Won't Lift, Even If You've Tried Everything

Board-certified psychiatric providers offer ketamine therapy, Spravato, and Ketamine-Assisted Psychotherapy for depression, anxiety, and PTSD that haven't responded to other treatments. Available in person at Cedars-Sinai Medical Office Towers in Los Angeles, West Hollywood, and Beverly Hills, or by telehealth anywhere in California.

  • HIPAA-compliant & confidential
  • Telehealth available statewide
  • 1:1 staff-to-patient ratio during treatment

Over 900,000 LA County residents live with depression, and many don't respond fully to standard antidepressants. If you've wondered whether ketamine therapy could help, it's worth a conversation with a psychiatric provider, not a guess.

If you are experiencing a mental health emergency or having thoughts of self-harm, call 988 (Suicide & Crisis Lifeline) or 911 immediately.

Care You Can't Get From an Infusion-Only Clinic

  • Real Psychiatric Providers Oversee Every Treatment

    Every ketamine and Spravato treatment plan is prescribed and supervised by a Board-certified psychiatric provider affiliated with Mental Health Center, not just an anesthesiologist or nurse running an infusion line. Your psychiatric provider can manage your full mental health treatment, not just the ketamine session.

  • Ketamine, Spravato, and Ketamine-Assisted Psychotherapy: All Outpatient
    For treatment-refractory depression, anxiety, and PTSD, MHC's Ketamine Therapy Center offers IV ketamine infusions, IM ketamine injections, Spravato (esketamine) nasal spray, and Ketamine-Assisted Psychotherapy, all delivered on an outpatient basis, with a 1:1 staff-to-patient ratio during treatment.
  • In-Person or Telehealth: Your Choice
    Receive ketamine infusion therapy in person at the Cedars-Sinai Medical Office Towers, serving Los Angeles county, West Hollywood, and Beverly Hills, or manage the rest of your psychiatric care via telehealth anywhere in California.

Do Any of These Sound Familiar?

Depression looks different for everyone. If you're experiencing any of the following, it may be time to talk to a psychiatrist:

You've tried two or more antidepressants without meaningful relief
Depression that feels persistent, heavy, or unresponsive to therapy alone
Anxiety or PTSD symptoms that haven't improved with standard treatment
You're in significant distress and want to understand options beyond a 4 to 6 week medication trial
You've heard about ketamine for depression but aren't sure if you're a candidate
You want treatment supervised by a psychiatric provider

If any of this sounds familiar, it's worth a conversation with a medical professional about whether ketamine therapy is right for you.

Schedule a Ketamine Consultation

Already Tried Antidepressants or Therapy Without Relief?

Treatment-refractory depression, depression that hasn't improved after two or more conventional antidepressants, is more common than most people realize. By the FDA definition (inadequate response to two or more adequate antidepressant trials), at least 30% of people with depression meet this definition [2]. Ketamine therapy offers a different mechanism of action than traditional antidepressants. Options include:

  • IV Ketamine Infusions & Intramuscular (IM) Ketamine Injections

    Administered by a registered nurse and supervised by a psychiatric provider affiliated with Mental Health Center, with a 1:1 staff-to-patient ratio during every session.

  • Spravato (Esketamine) Nasal Spray

    An FDA-approved ketamine-based nasal treatment for treatment-refractory depression, administered in-office under medical supervision.

  • Ketamine-Assisted Psychotherapy (KAP)

    Combines ketamine sessions with structured therapy to support deeper, longer-lasting progress. If you already have an outside therapist trained in KAP, they can qualify to join your sessions in person or remotely.

All ketamine treatment options are outpatient. No hospital stay or residential program required.

What Happens After You Reach Out

  • Submit Your
    Information

    Fill out the contact form above. Our office will follow up within 1 business day to schedule your discovery call or initial evaluation.

  • A Personalized Ketamine Treatment Plan

    Your psychiatric provider builds a plan around you: session frequency, dosing, and whether ketamine is combined with psychotherapy or ongoing medication management. The plan adjusts as you progress.

  • A Personalized Treatment
    Plan

    Your psychiatrist builds a plan around you - whether that's medication management, therapy, Ketamine/Spravato, or a combination - and adjusts as you progress.

If this is your first time being prescribed Ketamine, no referral is required.

Meet the Medical Professionals

Mental Health Center's Ketamine Therapy Center is located within the Cedars-Sinai Medical Office Towers in Los Angeles. The psychiatric providers affiliated with MHC treat adolescents through geriatric patients for treatment-refractory depression, anxiety, and PTSD, using ketamine, Spravato, and Ketamine-Assisted Psychotherapy as part of a broader, evidence-based treatment approach.

Common Questions

You Don't Have to Keep Managing This Alone

Talk to a board-certified psychiatric provider about ketamine therapy, and find out whether IV/IM ketamine, Spravato, or Ketamine-Assisted Psychotherapy is right for you.

Los Angeles county, West Hollywood, or Beverly Hills, or telehealth anywhere in California. Confidential. No referral needed.

📍 8631 W. 3rd St., Suite 1100E, Los Angeles, CA 90048📞 Phone: (424) 622-7375 

If you are experiencing a mental health emergency, call 911 or 988.

Sources

[1] Murrough JW, Iosifescu DV, Chang LC, et al. Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial. American Journal of Psychiatry. 2013;170(10):1134-1142. A single ketamine infusion produced a 64% response rate at 24 hours, versus 28% for active placebo (midazolam), in patients with treatment-resistant depression.

[2] Murrough JW, Perez AM, Pillemer S, et al. Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression. Biological Psychiatry. 2013;74(4):250-256. In an open-label study of 24 patients with treatment-resistant depression, a series of up to six IV ketamine infusions administered three times weekly over 12 days produced an overall response rate of 70.8% by study end; the study was not placebo-controlled.